12/16
08:04 am
agl
agilon health, inc. (NYSE: AGL) is now covered by analysts at Macquarie. They set a "neutral" rating on the stock.
Medium
Report
agilon health, inc. (NYSE: AGL) is now covered by analysts at Macquarie. They set a "neutral" rating on the stock.
12/11
08:01 am
agl
agilon health, inc. (NYSE: AGL) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $2.50 price target on the stock.
Medium
Report
agilon health, inc. (NYSE: AGL) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $2.50 price target on the stock.
11/19
11:40 am
agl
agilon health, inc. (NYSE: AGL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $3.00 price target on the stock.
Low
Report
agilon health, inc. (NYSE: AGL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $3.00 price target on the stock.
11/19
05:49 am
agl
New Strong Sell Stocks for November 19th [Yahoo! Finance]
Neutral
Report
New Strong Sell Stocks for November 19th [Yahoo! Finance]
11/13
12:53 pm
agl
agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at Citigroup Inc. from $2.50 to $1.75. They now have a "sell" rating on the stock.
Low
Report
agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at Citigroup Inc. from $2.50 to $1.75. They now have a "sell" rating on the stock.
11/12
02:31 pm
agl
agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at Stifel Nicolaus from $7.00 to $2.00. They now have a "hold" rating on the stock.
Low
Report
agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at Stifel Nicolaus from $7.00 to $2.00. They now have a "hold" rating on the stock.
11/12
08:30 am
agl
agilon health Reports ACO REACH Model Results for 2023 Performance Year
Medium
Report
agilon health Reports ACO REACH Model Results for 2023 Performance Year
11/11
11:18 am
agl
agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at TD Cowen from $6.00 to $2.00. They now have a "hold" rating on the stock.
Medium
Report
agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at TD Cowen from $6.00 to $2.00. They now have a "hold" rating on the stock.
11/11
09:02 am
agl
agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at Barclays PLC from $5.00 to $2.00. They now have an "underweight" rating on the stock.
High
Report
agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at Barclays PLC from $5.00 to $2.00. They now have an "underweight" rating on the stock.
11/11
07:47 am
agl
agilon health, inc. (NYSE: AGL) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
High
Report
agilon health, inc. (NYSE: AGL) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
11/8
02:48 am
agl
Agilon Health Inc (AGL) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges [Yahoo! Finance]
Medium
Report
Agilon Health Inc (AGL) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges [Yahoo! Finance]
11/7
07:48 pm
agl
Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings [Yahoo! Finance]
Medium
Report
Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings [Yahoo! Finance]
11/7
04:00 pm
agl
agilon health Reports Third Quarter 2024 Results
High
Report
agilon health Reports Third Quarter 2024 Results
11/6
07:41 am
agl
Agilon Health Inc (AGL) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
Medium
Report
Agilon Health Inc (AGL) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
11/5
04:00 pm
agl
agilon health to Participate at 2024 Wolfe Research Healthcare Conference
Medium
Report
agilon health to Participate at 2024 Wolfe Research Healthcare Conference
10/29
09:00 pm
agl
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Low
Report
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
10/29
06:19 pm
agl
agilon health, inc. (NYSE: AGL) had its "sell" rating re-affirmed by analysts at Citigroup Inc.. They now have a $2.50 price target on the stock, down previously from $7.00.
Neutral
Report
agilon health, inc. (NYSE: AGL) had its "sell" rating re-affirmed by analysts at Citigroup Inc.. They now have a $2.50 price target on the stock, down previously from $7.00.
10/25
05:22 pm
agl
AGILON HEALTH INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc. - AGL
Low
Report
AGILON HEALTH INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc. - AGL
10/17
04:00 pm
agl
agilon health Sets Date to Report Third Quarter 2024 Financial Results
Medium
Report
agilon health Sets Date to Report Third Quarter 2024 Financial Results
10/11
07:49 pm
agl
AGILON HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc. - AGL
Medium
Report
AGILON HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc. - AGL
10/8
12:57 pm
agl
agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at Evercore ISI from $7.00 to $4.00. They now have an "in-line" rating on the stock.
Low
Report
agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at Evercore ISI from $7.00 to $4.00. They now have an "in-line" rating on the stock.
10/2
04:13 pm
agl
agilon health, inc. (NYSE: AGL) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $3.00 price target on the stock.
Medium
Report
agilon health, inc. (NYSE: AGL) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $3.00 price target on the stock.
9/30
12:01 pm
agl
AGILON HEALTH INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc. - AGL
Low
Report
AGILON HEALTH INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc. - AGL